Michèle Rizzolio

902 total citations
22 papers, 616 citations indexed

About

Michèle Rizzolio is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michèle Rizzolio has authored 22 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michèle Rizzolio's work include Cannabis and Cannabinoid Research (6 papers), Sleep and related disorders (3 papers) and Alcohol Consumption and Health Effects (3 papers). Michèle Rizzolio is often cited by papers focused on Cannabis and Cannabinoid Research (6 papers), Sleep and related disorders (3 papers) and Alcohol Consumption and Health Effects (3 papers). Michèle Rizzolio collaborates with scholars based in United States, Netherlands and Switzerland. Michèle Rizzolio's co-authors include Sandra R. Chaplan, J. Guy Breitenbucher, Leon Chang, Nicholas I. Carruthers, Brian Lord, Manfred Schlosser, Christian Margot, Chandra Shah, Lin Luo and Michael H. Rabinowitz and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.

In The Last Decade

Michèle Rizzolio

22 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michèle Rizzolio United States	12	181	117	104	103	95	22	616
Chizuko Yamamoto Japan	19	301 1.7×	36 0.3×	166 1.6×	88 0.9×	48 0.5×	48	1.1k
Naoya Matsunaga Japan	18	222 1.2×	135 1.2×	21 0.2×	67 0.7×	17 0.2×	27	905
Ryan D. White United States	15	335 1.9×	196 1.7×	112 1.1×	86 0.8×	67 0.7×	21	1.2k
Carolyn A. Lister United Kingdom	15	570 3.1×	126 1.1×	115 1.1×	190 1.8×	5 0.1×	15	1.2k
Mitsuhiro Makino Japan	17	204 1.1×	69 0.6×	77 0.7×	16 0.2×	14 0.1×	36	739
Eiichi Sakurai Japan	17	261 1.4×	20 0.2×	56 0.5×	35 0.3×	101 1.1×	67	696
Maristella Adami Italy	16	355 2.0×	301 2.6×	189 1.8×	40 0.4×	59 0.6×	57	1.1k
Leanne Cutler United Kingdom	8	156 0.9×	14 0.1×	86 0.8×	214 2.1×	10 0.1×	10	659
Sine Mandrup Bertozzi Italy	16	272 1.5×	128 1.1×	162 1.6×	77 0.7×	6 0.1×	34	721

Countries citing papers authored by Michèle Rizzolio

Since Specialization

Citations

This map shows the geographic impact of Michèle Rizzolio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Rizzolio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Rizzolio more than expected).

Fields of papers citing papers by Michèle Rizzolio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Rizzolio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Rizzolio. The network helps show where Michèle Rizzolio may publish in the future.

Co-authorship network of co-authors of Michèle Rizzolio

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Rizzolio. A scholar is included among the top collaborators of Michèle Rizzolio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Rizzolio. Michèle Rizzolio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2020). Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 30(20). 127463–127463. 4 indexed citations

McDuffie, J. Eric, Ying Jing, Yunhai Zhang, et al.. (2017). Immunolocalization of novel corticomedullary tubule injury markers in Cynomolgus monkeys treated with amphotericin B. The Journal of Toxicological Sciences. 42(2). 167–174. 4 indexed citations

Keith, John M., Mark S. Tichenor, Richard L. Apodaca, et al.. (2016). The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(13). 3109–3114. 11 indexed citations

McDuffie, J. Eric, Karen Lynch, Linh T. Nguyen, et al.. (2016). Cisplatin nephrotoxicity in male beagle dogs: next-generation protein kidney safety biomarker tissue expression and related changes in urine. Toxicology Research. 5(4). 1202–1215. 13 indexed citations

Bonaventure, Pascal, Jonathan Shelton, Sujin Yun, et al.. (2015). Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. Journal of Pharmacology and Experimental Therapeutics. 354(3). 471–482. 71 indexed citations

Keith, John M., W. M. Jones, Mark S. Tichenor, et al.. (2015). Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS Medicinal Chemistry Letters. 6(12). 1204–1208. 47 indexed citations

Letavic, Michael A., Pascal Bonaventure, Nicholas I. Carruthers, et al.. (2015). Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate. Journal of Medicinal Chemistry. 58(14). 5620–5636. 37 indexed citations

Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2014). Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(3). 737–741. 24 indexed citations

Keith, John M., Natalie A. Hawryluk, Richard L. Apodaca, et al.. (2014). 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(5). 1280–1284. 11 indexed citations

10.

Wiener, John J. M., Steven Nguyen, Siquan Sun, et al.. (2012). Pyrazole-based arylalkyne Cathepsin S inhibitors. Part III: Modification of P4 region. Bioorganic & Medicinal Chemistry Letters. 23(4). 1070–1074. 7 indexed citations

11.

Keith, John M., Richard L. Apodaca, Mark S. Tichenor, et al.. (2012). Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate. ACS Medicinal Chemistry Letters. 3(10). 823–827. 31 indexed citations

12.

Barrett, Terrance D., Kimon C. Kanelakis, Xiaodong Wu, et al.. (2011). Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor. Molecular Pharmacology. 79(6). 910–920. 65 indexed citations

13.

Morton, Magda F., Terrance D. Barrett, Jamie Freedman, et al.. (2011). JNJ-26070109 [(R)4-Bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: A Novel, Potent, and Selective Cholecystokinin 2 Receptor Antagonist with Good Oral Bioavailability. Journal of Pharmacology and Experimental Therapeutics. 338(1). 328–336. 5 indexed citations

14.

Hickey, Magali B., et al.. (2011). Spontaneous Gelation of a Novel Histamine H4 Receptor Antagonist in Aqueous Solution. Pharmaceutical Research. 28(10). 2556–2566. 6 indexed citations

15.

Kanelakis, Kimon C., Lina Li, Jiejun Wu, et al.. (2009). Characterization of a Robust Enzymatic Assay for Inhibitors of 2-Oxoglutarate-Dependent Hydroxylases. SLAS DISCOVERY. 14(6). 627–635. 13 indexed citations

16.

Lebsack, Alec D., Michael D. Hack, Wei Xiao, et al.. (2008). Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(1). 40–46. 18 indexed citations

17.

Morton, Magda F., Terrance D. Barrett, Wen Yan, et al.. (2007). 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1 H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a Novel, Potent, and Selective Cholecystokinin 1 Receptor Antagonist: In Vitro and in Vivo Pharmacological Comparison with Dexloxiglumide. Journal of Pharmacology and Experimental Therapeutics. 323(2). 562–569. 6 indexed citations

18.

Swanson, Devin M., Adrienne E. Dubin, Chandra Shah, et al.. (2004). Identification and Biological Evaluation of 4-(3-Trifluoromethylpyridin-2-yl)piperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a High Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist. Journal of Medicinal Chemistry. 48(6). 1857–1872. 144 indexed citations

19.

Rabinowitz, Michael H., Robert Andrews, J. David Becherer, et al.. (2001). Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE). Journal of Medicinal Chemistry. 44(24). 4252–4267. 57 indexed citations

20.

Ayanoĝlu, Eser, et al.. (1990). Covalently bound fatty acids in membrane proteins of some sponges. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 96(3). 597–603. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact